PoliCheck Network
← Back to bills
H.R. 4752119th CongressReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Reducing Hereditary Cancer Act

Introduced: Jul 23, 2025
Latest action: Jul 23, 2025

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

1
Primary Sponsors
15
Cosponsors
2
Recorded Actions
0
Linked Votes

Plain-English AI Summary

What this bill means

Generated from the official bill text to make the legislation easier to understand.

Not Generated

A plain-English AI summary has not been generated for this bill yet.

Official Summary

Official legislative summary associated with this bill.

Reducing Hereditary Cancer Act This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Primary Sponsors

Members listed as primary sponsors of this legislation.

Cosponsors

Members who joined this legislation as cosponsors.

Recorded Actions

Official legislative actions recorded for this measure.

H11100Jul 23, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Official source ↗
Intro-HJul 23, 2025

Introduced in House

Official source ↗

Linked Votes

Roll-call votes associated with this legislation.

No roll-call votes are currently linked to this bill.

Lobbying Activity

Federal lobbying disclosures that explicitly identify H.R. 4752. These records show reported lobbying involving the legislation; they do not establish that every member of Congress, sponsor, or voter was personally contacted.

EISAI INC.

Registrant: EISAI INC.

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Medicare/Medicaid: General issues related to Medicare and Medicaid, including: Part D Medicare Program; CMMI Drug Pricing Demonstration Programs; drug pricing; Alzheimers Screening and Prevention Act (ASAP) (HR 6130, S 3267); Concentrating on High-value Alzheimers Needs to Get to an End Act (CHANGE) (HR 4752. S 2379). Taxation/Internal Revenue Code: Issues related to tax reform; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation. Trade (domestic/foreign): Issues related to supply chain manufacturing and tariffs; Section 232 tariff investigation on branded pharmaceuticals. Copyright/Patent/Trademark: Issues related to pharmaceutical Intellectual Property (IP). Manufacturing: Issues related to pharmaceutical manufacturing. Health Issues: Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act; PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $460,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

EXACT SCIENCES

Registrant: EXACT SCIENCES

4th Quarter (Oct 1 - Dec 31)
Jan 22, 2026

Reported lobbying issue

Medicare/Medicaid: HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. Support colorectal cancer screening standards Health Issues: Support patient access to cancer screening and diagnostics. Support HR 1780/S 642 Finn Sawyer Access to Cancer Testing Act Support S 1410 Find It Early Act Support HR 2921/S 2745 Federal Firefighter Cancer Detection and Prevention Act of 2025 Support HR 1610 FIRE Cancer Act Support HR 4752/S 2760 Reducing Hereditary Cancer Act Support HR 7714 Colorectal Cancer Early Detection Act Support S 1717 Ensuring Patient Access to Critical Breakthrough Products Act Veterans: Support veteran access to guideline-recommended colorectal cancer screening.

Government entities reported: Centers For Medicare and Medicaid Services (CMS) HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $420,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

EXACT SCIENCES

Registrant: EXACT SCIENCES

3rd Quarter (July 1 - Sep 30)
Oct 23, 2025

Reported lobbying issue

Veterans: Support veteran access to guideline-recommended colorectal cancer screening. Medicare/Medicaid: HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act: This bill allows, beginning in 2028, for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. Coverage is limited to those under a certain age (age 68 in 2028, increased by one year every year thereafter) and to one test every 11 months. Health Issues: Support patient access to cancer screening and diagnostics. Support HR 1780/S 642 Finn Sawyer Access to Cancer Testing Act Support S 1410 Find It Early Act Support HR 2921/S 2745 Federal Firefighter Cancer Detection and Prevention Act of 2025 Support HR 1610 FIRE Cancer Act Support HR 4752/S 2760 Reducing Hereditary Cancer Act Support HR 7714 Colorectal Cancer Early Detection Act Support S 1717 Ensuring Patient Access to Critical Breakthrough Products Act

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Health & Human Services, Dept of (HHS)

Reported filing-period amount: $450,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

EISAI INC.

Registrant: EISAI INC.

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Trade (domestic/foreign): Supply chain manufacturing and tariffs, including: the Section 232 and Section 301 tariff investigations related to branded pharmaceuticals. Copyright/Patent/Trademark: Pharmaceutical Intellectual Property (IP), including: S. 2658, Medication Affordability and Patent Integrity Act. Manufacturing: Pharmaceutical manufacturing. Health Issues: Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; pharmaceutical scheduling; Pharmacy Benefit Manager (PBM) reform, 340B Drug Discount Program. Medicare/Medicaid: General Medicare and Medicaid including: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order; Part D Program; Center for Medicare and Medicaid Innovation (CMMI) Drug Pricing Demonstration Programs; drug pricing, PBM reform; H.R. 6130 / S. 3267, the Alzheimers Screening and Prevention (ASAP) Act; H.R. 4752 / S. 2379, the Concentrating on High-value Alzheimers Needs to Get to an End (CHANGE) Act; H.R. 3747, the Accelerating Access to Dementia and Alzheimers Provider Training (AADAPT) Act Taxation/Internal Revenue Code: Tax reform, including: H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $790,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

ASSOCIATION FOR CLINICAL ONCOLOGY

Registrant: ASSOCIATION FOR CLINICAL ONCOLOGY

2nd Quarter (Apr 1 - June 30)
Jul 16, 2026

Reported lobbying issue

Medicare/Medicaid: H.R. 3514/S. 1816: Improving Seniors' Timely Access to Care Act of 2025 - requires Medicare Advantage plans to implement electronic prior authorization, increase transparency, protect enrollees, and adhere to new response timeframes to improve timely access to care. H.R. 2433: Reducing Medically Unnecessary Delays in Care Act - mandates that prior authorization decisions under Medicare be made by qualified physicians, based on medical necessity and evidence-based standards, with transparency and input from practicing physicians. S. 1640/H.R. 879: Medicare Patient Access and Practice Stabilization Act of 2025 - This bill increases certain payment adjustments under the Medicare physician fee schedule for services furnished between April 1, 2025, and January 1, 2026. H.R. 8163: Provider Reimbursement Stability Act, to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program. H.R. 8622: Medicare Physician Data-driven Performance Payment System Act to amend title XVIII of the Social Security Act to transform the Merit-based Incentive Payment System into the Data-driven Performance Payment System under the Medicare physician fee schedule H.R. 6160: Strengthening Medicare for Patients and Providers Act to modify certain adjustments to payment amounts under the Medicare physician fee schedule S. 1460/H.R. 786: Preserving Patient Access to Accountable Care Act - extends Medicare incentive payments for alternative payment models to 2027, with a new rate of 3.53 percent, to promote continued participation and improve healthcare efficiency. H.R. 2120/S. 1031: ROCR Value Based Program Act - establishes a new payment program for radiation oncology services, focusing on stable payments, quality care, and patient access, while exempting it from budget neutrality adjustments. H.R. 4559: Prompt and Fair Pay Act - to establish payment parity between Medicare Advantage and fee-for-service Medicare, and to establish prompt payment requirements under Medicare Advantage. H.R. 2484: Seniors' Access to Critical Medications Act of 2025 - establishes an exception to the physician self-referral prohibition for certain outpatient drugs under Medicare, mandates a study on drug dispensing practices, and reduces the Medicare improvement fund by $18 million. H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act - provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation H.R. 4206/S. 1261: CONNECT for Health Act - expands access to telehealth services under Medicare H.R. 5081/S. 2709: Telehealth Modernization Act - to extend certain telehealth flexibilities under the Medicare program. H.R. 4752/S. 2760: Reducing Hereditary Cancer Act - to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation. Health Issues: H.R. 6423/S. 864: HELP Copays Act - requires health insurers to count third-party financial assistance toward patients' cost-sharing obligations, including deductibles and copays, for prescription drugs, with changes effective for plan years beginning January 1, 2026. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. H.R. 8339: Drug Origin Transparency Act to amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting H.R. 5526/S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral anticancer drugs that is at least as favorable as for provider-administered anticancer medications, with protections against increased patient costs and a mandated GAO study on the law's impact. H.R. 3521/S. 4440: Clinical Trials Modernization Act - Increase clinical trial participation among underrepresented populations by providing grants, permitting certain participant reimbursements, and offering tax exclusions, while ensuring compliance with existing legal protections. S. 705: Innovation in Pediatric Drugs Act of 2025 - amends existing laws to enhance pediatric cancer research, mandates compliance measures, allocates funding for pediatric studies, and sets guidelines for orphan drugs, with specific timelines for implementation and evaluation. H.R. 5509/S. 2903: Safe Step Act - to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. H.R. 4425/S. 2287: Palliative Care and Hospice Education and Training Act - expands federal support for workforce development, education, public awareness, and research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses. H.R. 8839: Lainie Jones Comprehensive Cancer Survivorship Act of 2026 to address the health of cancer survivors. Budget/Appropriations: FY 2026 and FY 2027 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Congressionally Directed Medical Research Programs (CDMRP).

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $480,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN TRUCKING ASSOCIATIONS

Registrant: AMERICAN TRUCKING ASSOCIATIONS

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Environment/Superfund: H.R. 346 / S. 996 - Preserving Choice in Vehicle Purchase Act; H.R. 2814 / S. 711 - Transportation Freedom Act; S. 990 Freedom to Haul Act; H.R. 2218 / S. 1027 - Stop CARB Act; H.R. 2140 / S. 2235 - Diesel Emissions Reduction Act; H.R. 6250 / S. 3135 - Cold Weather Diesel Reliability Act; S. 25 - Polluters pay Climate Fund Act; and H.R. 2460 - Eliminating the RFS and its Destructive Outcomes Act. Environmental issues related to Hazardous Materials, Air Quality, Vehicle Emissions, Diesel Issues (retrofits), Motor Carriers, Biodiesel/Renewable Diesel, EPA SmartWay Voluntary Program, GHG/FE Phase 3 Labor Issues/Antitrust/Workplace: H.R. 623 / S. 191 - The LICENSE Act; H.R. 5408 / S. 844 - Faster Labor Contracts Act; H.R. 2945 / 1537 - Veterans Transition to Trucking Act; H.R. 3055 - TRANSPORT Jobs Act; H.R. 4049 - Employer Directed Skills Act; H.R. 5109 - The TWICE Act; H.R. 982 - Warriors to Workforce Act; H.R. 5295 - ACCESS Act; H.R. 5296 - BUILDS Act; H.R. 5297 - PARTNERS Act; H.R. 5563 - DRIVE Safe Act; H.R. 1232 / S. 533 - National Right-to-Work Act H.R. 1319 / S. 2228 - Modern Worker Empowerment Act; H.R. 1320 - Modern Worker Security Act; H.R. 20 / S. 852 - Protecting the Right to Organize Act; H.R. 1962 / S. 893 - Guaranteeing Overtime for Truckers Act; H.R. 4500 - HELP Act; and H.R. 4896 / S. 2613 - Warehouse Worker Protection Act. Implementation of P.L. 119-21 - One Big Beautiful Bill Act - provisions related to workforce Pell Grants. Other workforce and labor issues included Hours of Service reform, Independent Contractors, Truck Driver Shortages, Veteran Employment Training Act, the NLRB, and the Fair Labor Standards Act Small Business: H.R. 354 - Small Business Growth Act. Small business issues related to Truck Driver Training, Hazardous Materials, Border Security and Safety, Transportation Security, Homeland Security Issues, Trucking/Motor Carrier Issues, Taxes, Fuel, Independent Contractors, Hours of Service Taxation/Internal Revenue Code: H.R. 2424 - the Modern, Clean and Safe Trucks Act; H.R. 2391 - the Strengthening Supply Chains through Truck Driver Incentives Act; H.R. 1301 / S. 587 - Death Tax Repeal Act; H.R. 574, S.187 - The Align Act; H.R. 703 / S. 213 - Main Street Tax Certainty Act; H.R. 1177 / S 492 - Improve and Enhance Work Opportunity Act; H.R. 1253 / S. 536 - Fair Share Act; H.R. 3338 - MARKET Choice Act; H.R. 3401 / S. 2790 - Retreated Truck Tire Jobs, Supply Chain Security and Sustainability Act; H.R. 3137 - Biodiesel Tax Credit Extension Act; S. 3297 - Consumer Relief and Opportunities for Producers Act; and H.R. 2596 / S. 1252 - Renewable Natural Gas Incentive Act. Implementation of P.L. 119-21 - One Big Beautiful Bill Act - Tax and workforce provisions related to passthrough entities. Tax issues relating to Motor Carrier Tax, Highway Reauthorization, Highway Funding, Fuel Tax, Independent Contractors, Tolling, Heavy Vehicle Use Tax, Federal Highway Trust Fund, Alternative Fuel Tax Credit and the Biodiesel Tax Credit, and the Moving Expense Tax Deduction Roads/Highway: H.R. 1659 - Truck Parking Safety Improvement Act; H.R. 3972 / S. 1066 - Highway Funding Flexibility Act; H.R. 352 - A Bill to Prohibit Cordon Pricing in the Central Business District Tolling Program for New York City; H.R. 351 - A Bill to Prohibit Congestion or Cordon Pricing in a Value Pricing; H.R. 851 / S. 415 - DOT Victim and Survivor Advocate Act; H.R. 7261 - Motor Carrier Safety Screening Modernization Act; S. 3572 /H.R. 6874)Roadway Safety Modernization Act; H.R. 6351 - Bridges Not Bumpers Act; and H.R. 4776 - SPEED Act. Other road/highway issues relating to highway funding, highway infrastructure, motor carrier taxes, public private partnerships, hours of service, truck productivity, tolling and devolution, truck-only vehicle miles traveled taxes. Trucking/Shipping: H.R.2514 - Trucker Bathroom Access Act; H.R. 2920 / S.2108 - VARIANCE Act; H.R. 4802 - Securing Infrastructure from Adversaries Act; H.R. 4661 - America DRIVES Act; S. 2290 - Collision Avoidance Systems Act; H.R. 5423 - Predatory Truck Leasing Prevention Act; and S. 1071 - National Defense Authorization Act - provisions related to base and bathroom access, DOD contracting for the movement of military goods, the relocation of military families. Other Trucking issues include Hazardous Materials, Government Traffic, Hours of Service, Public Private Partnerships, Tolling, Background Check, Highway Funding, Transportation Worker ID, Fuel Supply and Cost Issues, Economic Issues and Federal Pre-emption Budget/Appropriations: H.R. 4552 / S. 2465 - Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026 - provisions related to alternative warning devices, cargo theft reports, ELDT training provider registry, English language proficiency, human trafficking, federal preemption determination; marijuana impartment standards, predatory towing report language Safe Driver Apprenticeship Pilot Program and trucking parking language; H.R. 4249 - Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations Act, 2026, provisions related to hair testing reports, and IC Rule funding; H.R. 4213 - Homeland Security Appropriations Bill, 2026 - provisions related to cargo theft; H.R. 4752 - Department of Interior and related Agencies Act, 2026 - provisions related to EPA GHG3 rules; H.R. 5332 / S. 2354 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 - provisions related to cargo theft. Other Appropriations Issues related to Transportation, Transportation Security, Homeland Security, Environmental, Hours of Service, Motor Carrier Safety, Productivity, Tolling, Highway Trust Fund, Hair Testing, Independent Contractors, Younger Driver Pilot Program, Apprenticeship Programs Trade (domestic/foreign): H.R. 252 - Secure Our Ports Act; H.R. 1297 - Land Port of Entry Modernization Trust Fund Act; H.R. 1297 / S. 578 - BEST Facilitation Act; H.R. 2444 / S. 257 - Promoting Resilient Supply Chains Act; and H.R. 3630 / S. 711 - International Bridge and Port of Entry Modernization Act. Law Enforcement/Crime/Criminal Justice: H.R. 880 / S. 337 - Household Goods Shipping Consumer Protection; H.R. 863 / S. 61 - National Human Trafficking Database Act; H.R. 1569 / S. 703 - CATCH Fentanyl Act; H.R. 3608 / S. 2991 - Connors Law; H.R. 3799 - Executive Order 14286 Act of 2025; H.R. 2853 / S.1404 - Combatting Organized Retail Crime Act; S. 1442 - Combating Trafficking in Transportation Act; H.R. 4320 - Drug and Alcohol Clearinghouse Public Safety Improvement Act; S. 2238 / H.R. 5221 - The PART Act; S. 2690 - Safer Truckers Act; H.R. 5177 - Weigh Act; H.R 5688 / S. 3917 / S. 4224 - Daliahs Act;H,R. 7539 - Safety and Accountability in Freight Enforcement (SAFE) Act; H.R. 8267 / S. 3950 - Securing American Freight, Enforcement, and Reliability (SAFER) Transport Act; H.R. 5800 - Safe Drivers Act; S. 3109 - TRAFFIC Act; S. 3110 - Stop Human Trafficking Act; S. 3376 - Cargo Security Innovation Act; and H.R.7354 / S. 3775 / Stop Underrides Act. Torts: H.R. 1109 - Litigation Transparency Act; H.R. 2662 - Staged Accident Fraud Prevention Act; H.R. 2675 / S. 3180 - Protecting Our Courts from Foreign Manipulation Act; H.R. 3512 / S. 1821 - Tackling Predatory Litigation Funding Act; H.R. 5258 - Lawsuit Abuse Reduction Act; and H.R. 5268 - FAIR Trucking Act.

Government entities reported: Environmental Protection Agency (EPA) Federal Highway Administration (FHA) HOUSE OF REPRESENTATIVES SENATE White House Office Federal Motor Carrier Safety Administration Labor, Dept of (DOL) Transportation, Dept of (DOT) Homeland Security, Dept of (DHS) Internal Revenue Service (IRS) Office of Management & Budget (OMB) U.S. International Trade Commission (ITC) U.S. Trade Representative (USTR)

Reported filing-period amount: $620,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

ASSOCIATION FOR CLINICAL ONCOLOGY

Registrant: ASSOCIATION FOR CLINICAL ONCOLOGY

1st Quarter (Jan 1 - Mar 31)
Apr 15, 2026

Reported lobbying issue

Medicare/Medicaid: H.R. 3514/S. 1816: Improving Seniors' Timely Access to Care Act of 2025 - requires Medicare Advantage plans to implement electronic prior authorization, increase transparency, protect enrollees, and adhere to new response timeframes to improve timely access to care. S. 1640/H.R. 879: Medicare Patient Access and Practice Stabilization Act of 2025 - This bill increases certain payment adjustments under the Medicare physician fee schedule for services furnished between April 1, 2025, and January 1, 2026. S. 1460/H.R. 786: Preserving Patient Access to Accountable Care Act - extends Medicare incentive payments for alternative payment models to 2027, with a new rate of 3.53 percent, to promote continued participation and improve healthcare efficiency. H.R. 4206/S. 1261: CONNECT for Health Act - expands access to telehealth services under Medicare H.R. 2433: Reducing Medically Unnecessary Delays in Care Act - mandates that prior authorization decisions under Medicare be made by qualified physicians, based on medical necessity and evidence-based standards, with transparency and input from practicing physicians. H.R. 1509/S. 752: Accelerating Kids Access to Care Act - To amend titles XIX and XXI of the Social Security Act to streamline the enrollment process for eligible out-of-state providers under Medicaid and CHIP. H.R. 2484: Seniors' Access to Critical Medications Act of 2025 - establishes an exception to the physician self-referral prohibition for certain outpatient drugs under Medicare, mandates a study on drug dispensing practices, and reduces the Medicare improvement fund by $18 million. H.R. 2120/S. 1031: ROCR Value Based Program Act - establishes a new payment program for radiation oncology services, focusing on stable payments, quality care, and patient access, while exempting it from budget neutrality adjustments. H.R. 4559: Prompt and Fair Pay Act - to establish payment parity between Medicare Advantage and fee-for-service Medicare, and to establish prompt payment requirements under Medicare Advantage. H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act - provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation. H.R. 5081/S. 2709: Telehealth Modernization Act - to extend certain telehealth flexibilities under the Medicare program. H.R. 4752/S. 2760: Reducing Hereditary Cancer Act - to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation. Health Issues: H.R. 6423/S. 864: HELP Copays Act - requires health insurers to count third-party financial assistance toward patients' cost-sharing obligations, including deductibles and copays, for prescription drugs, with changes effective for plan years beginning January 1, 2026. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 1262/S. 932: Mikaela Naylon Give Kids a Chance Act of 2025 - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. HR 929/S.266: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act - To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes. H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral anticancer drugs that is at least as favorable as for provider-administered anticancer medications, with protections against increased patient costs and a mandated GAO study on the law's impact. H.R. 3521: Clinical Trials Modernization Act - Increase clinical trial participation among underrepresented populations by providing grants, permitting certain participant reimbursements, and offering tax exclusions, while ensuring compliance with existing legal protections. S. 705: Innovation in Pediatric Drugs Act of 2025 - amends existing laws to enhance pediatric cancer research, mandates compliance measures, allocates funding for pediatric studies, and sets guidelines for orphan drugs, with specific timelines for implementation and evaluation. H.R. 5509/S. 2903: Safe Step Act - to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. H.R. 4425/S. 2287: Palliative Care and Hospice Education and Training Act - expands federal support for workforce development, education, public awareness, and research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses. Budget/Appropriations: FY 2026 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP). FY 2027 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP).

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $210,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN TRUCKING ASSOCIATIONS

Registrant: AMERICAN TRUCKING ASSOCIATIONS

4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026

Reported lobbying issue

Environment/Superfund: H.R. 346 / S. 996 - Preserving Choice in Vehicle Purchase Act; H.R. 2814 / S. 711 - Transportation Freedom Act; S. 990 Freedom to Haul Act; H.R. 2218 / S. 1027 - Stop CARB Act; H.R. 2140 / S. 2235 - Diesel Emissions Reduction Act; H.R. 6250 / S. 3135 - Cold Weather Disel Reliability Act; S. 25 - Polluters pay Climate Fund Act; and H.R. 2460 - Eliminating the RFS and its Destructive Outcomes Act. Environmental issues related to Hazardous Materials, Air Quality, Vehicle Emissions, Diesel Issues (retrofits), Motor Carriers, Biodiesel/Renewable Diesel, EPA SmartWay Voluntary Program, GHG/FE Phase 3 Labor Issues/Antitrust/Workplace: H.R. 623 / S. 191 - The LICENSE Act; S. 844 - Faster Labor Contracts Act; H.R. 2945 / 1537 - Veterans Transition to Trucking Act; H.R. 3055 - TRANSPORT Jobs Act; H.R. 4049 - Employer Directed Skills Act; H.R. 5109 - The TWICE Act; H.R. 982 - Warriors to Workforce Act; H.R. 5295 - ACCESS Act; H.R. 5296 - BUILDS Act; H.R. 5297 - PARTNERS Act; H.R. 5563 - DRIVE Safe Act; H.R. 1232 / S. 533 - National Right-to-Work Act H.R. 1319 / S. 2228 - Modern Worker Empowerment Act; H.R. 1320 - Modern Worker Security Act; H.R. 20 / S. 852 - Protecting the Right to Organize Act; H.R. 1962 / S. 893 - Guaranteeing Overtime for Truckers Act; H.R. 4500 - HELP Act; and H.R. 4896 / S. 2613 - Warehouse Worker Protection Act. Implementation of P.L. 119-21 - One Big Beautiful Bill Act - provisions related to workforce Pell Grants. Other workforce and labor issues included Hours of Service reform, Independent Contractors, Truck Driver Shortages, Veteran Employment Training Act, the NLRB, and the Fair Labor Standards Act Small Business: H.R. 354 - Small Business Growth Act. Small business issues related to Truck Driver Training, Hazardous Materials, Border Security and Safety, Transportation Security, Homeland Security Issues, Trucking/Motor Carrier Issues, Taxes, Fuel, Independent Contractors, Hours of Service Taxation/Internal Revenue Code: H.R. 2424 - the Modern, Clean and Safe Trucks Act; H.R. 2391 - the Strengthening Supply Chains through Truck Driver Incentives Act; H.R. 1301 / S. 587 - Death Tax Repeal Act; H.R. 574, S.187 - The Align Act; H.R. 703 / S. 213 - Main Street Tax Certainty Act; H.R. 1177 / S 492 - Improve and Enhance Work Opportunity Act; H.R. 1253 / S. 536 - Fair Share Act; H.R. 3338 - MARKET Choice Act; H.R. 3401 / S. 2790 - Retreated Truck Tire Jobs, Supply Chain Security and Sustainability Act; H.R. 3137 - Biodiesel Tax Credit Extension Act; S. 3297 - Consumer Relief and Opportunities for Producers Act; and H.R. 2596 / S. 1252 - Renewable Natural Gas Incentive Act. Implementation of P.L. 119-21 - One Big Beautiful Bill Act - Tax and workforce provisions related to passthrough entities. Tax issues relating to Motor Carrier Tax, Highway Reauthorization, Highway Funding, Fuel Tax, Independent Contractors, Tolling, Heavy Vehicle Use Tax, Federal Highway Trust Fund, Alternative Fuel Tax Credit and the Biodiesel Tax Credit, and the Moving Expense Tax Deduction Budget/Appropriations: H.R. 4552 / S. 2465 - Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026 - provisions related to alternative warning devices, cargo theft reports, ELDT training provider registry, English language proficiency, human trafficking, federal preemption determination; marijuana impartment standards, predatory towing report language Safe Driver Apprenticeship Pilot Program and trucking parking language; H.R. 4249 - Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations Act, 2026, provisions related to hair testing reports, and IC Rule funding; H.R. 4213 - Homeland Security Appropriations Bill, 2026 - provisions related to cargo theft; H.R. 4752 - Department of Interior and related Agencies Act, 2026 - provisions related to EPA GHG3 rules; H.R. 5332 / S. 2354 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 - provisions related to cargo theft. Other Appropriations Issues related to Transportation, Transportation Security, Homeland Security, Environmental, Hours of Service, Motor Carrier Safety, Productivity, Tolling, Highway Trust Fund, Hair Testing, Independent Contractors, Younger Driver Pilot Program, Apprenticeship Programs Roads/Highway: H.R. 1659 - Truck Parking Safety Improvement Act; H.R. 3972 / S. 1066 - Highway Funding Flexibility Act; H.R. 352 - A Bill to Prohibit Cordon Pricing in the Central Business District Tolling Program for New York City; H.R. 351 - A Bill to Prohibit Congestion or Cordon Pricing in a Value Pricing; H.R. 851 / S. 415 - DOT Victim and Survivor Advocate Act; and H.R. 4776 - SPEED Act. Other road/highway issues relating to highway funding, highway infrastructure, motor carrier taxes, public private partnerships, hours of service, truck productivity, tolling and devolution, truck-only vehicle miles traveled taxes. Trucking/Shipping: H.R.2514 - Trucker Bathroom Access Act; H.R. 2920 / S.2108 - VARIANCE Act; H.R. 4802 - Securing Infrastructure from Adversaries Act; H.R. 4661 - America DRIVES Act; S. 2290 - Collision Avoidance Systems Act; H.R. 5423 - Predatory Truck Leasing Prevention Act; and S. 1071 - National Defense Authorization Act - provisions related to base and bathroom access, DOD contracting for the movement of military goods, the relocation of military families. Other Trucking issues include Hazardous Materials, Government Traffic, Hours of Service, Public Private Partnerships, Tolling, Background Check, Highway Funding, Transportation Worker ID, Fuel Supply and Cost Issues, Economic Issues and Federal Pre-emption Trade (domestic/foreign): H.R. 252 - Secure Our Ports Act; H.R. 1297 - Land Port of Entry Modernization Trust Fund Act; H.R. 1297 / S. 578 - BEST Facilitation Act; H.R. 2444 / S. 257 - Promoting Resilient Supply Chains Act; and H.R. 3630 / S. 711 - International Bridge and Port of Entry Modernization Act. Law Enforcement/Crime/Criminal Justice: H.R. 880 / S. 337 - Household Goods Shipping Consumer Protection; H.R. 863 / S. 61 - National Human Trafficking Database Act; H.R. 1569 / S. 703 - CATCH Fentanyl Act; H.R. 3608 / S. 2991 - Connors Law; H.R. 3799 - Executive Order 14286 Act of 2025; H.R. 2853 / S.1404 - Combatting Organized Retail Crime Act; S. 1442 - Combating Trafficking in Transportation Act; H.R. 4320 - DAC Safety Act; S. 2238 / H.R. 5221 - The PART Act; S. 2690 - Safer Truckers Act; H.R. 5177 - Weigh Act; H.R 5688 - Non Domiciled CDL Integrity Act; H.R. 5800 - Safe Drivers Act; S. 3109 - TRAFFIC Act; S. 3110 - Stop Human Trafficking Act; and S. 3376 - Cargo Security Innovation Act. Torts: H.R. 1109 - Litigation Transparency Act; H.R. 2662 - Staged Accident Fraud Prevention Act; H.R. 2675 / S. 3180 - Protecting Our Courts from Foreign Manipulation Act; H.R. 3512 / S. 1821 - Tackling Predatory Litigation Funding Act; H.R. 5258 - Lawsuit Abuse Reduction Act; and H.R. 5268 - FAIR Trucking Act.

Government entities reported: Environmental Protection Agency (EPA) Federal Highway Administration (FHA) HOUSE OF REPRESENTATIVES SENATE White House Office Federal Motor Carrier Safety Administration Labor, Dept of (DOL) Transportation, Dept of (DOT) Internal Revenue Service (IRS) Office of Management & Budget (OMB) Homeland Security, Dept of (DHS) U.S. International Trade Commission (ITC) U.S. Trade Representative (USTR)

Reported filing-period amount: $560,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

ASSOCIATION FOR CLINICAL ONCOLOGY

Registrant: ASSOCIATION FOR CLINICAL ONCOLOGY

4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026

Reported lobbying issue

Medicare/Medicaid: H.R. 3514/S. 1816: Improving Seniors' Timely Access to Care Act of 2025 - requires Medicare Advantage plans to implement electronic prior authorization, increase transparency, protect enrollees, and adhere to new response timeframes to improve timely access to care. S. 1640: Medicare Patient Access and Practice Stabilization Act of 2025 - The bill extends Medicare payment adjustment timelines to 2025 and introduces an 8.51 percent adjustment for services between June 1, 2025, and January 1, 2026, to support healthcare providers in adapting to payment changes. S. 1460: Preserving Patient Access to Accountable Care Act - extends Medicare incentive payments for alternative payment models to 2027, with a new rate of 3.53 percent, to promote continued participation and improve healthcare efficiency. H.R. 4206/S. 1261: CONNECT for Health Act - expands access to telehealth services under Medicare H. 879: Medicare Patient Access and Practice Stabilization Act - Providing automatic inflationary updates to Medicare physician payments. Eliminate budget neutrality requirements. Meaningful changes to the Merit-Based Incentive Payment System (MIPS). H.R. 786: Preserving Patient Access to Accountable Care Act. Incentivizing the transition to value-based care. H.R. 2433: Reducing Medically Unnecessary Delays in Care Act - mandates that prior authorization decisions under Medicare be made by qualified physicians, based on medical necessity and evidence-based standards, with transparency and input from practicing physicians. H.R. 1509/S. 752: Accelerating Kids Access to Care Act - To amend titles XIX and XXI of the Social Security Act to streamline the enrollment process for eligible out-of-state providers under Medicaid and CHIP. H.R. 2484: Seniors' Access to Critical Medications Act of 2025 - establishes an exception to the physician self-referral prohibition for certain outpatient drugs under Medicare, mandates a study on drug dispensing practices, and reduces the Medicare improvement fund by $18 million. H.R. 2120/S. 1031: ROCR Value Based Program Act - establishes a new payment program for radiation oncology services, focusing on stable payments, quality care, and patient access, while exempting it from budget neutrality adjustments. H.R. 4559: Prompt and Fair Pay Act - to establish payment parity between Medicare Advantage and fee-for-service Medicare, and to establish prompt payment requirements under Medicare Advantage. H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act - provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation. H.R. 5081/S. 2709: Telehealth Modernization Act - to extend certain telehealth flexibilities under the Medicare program. H.R. 4752/S. 2760: Reducing Hereditary Cancer Act - to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation. Health Issues: H.R. 6423/S. 864: HELP Copays Act - requires health insurers to count third-party financial assistance toward patients' cost-sharing obligations, including deductibles and copays, for prescription drugs, with changes effective for plan years beginning January 1, 2026. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 1262/S. 932: Give Kids a Chance Act of 2025 - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. HR 929/S.266: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act - To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes. H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral anticancer drugs that is at least as favorable as for provider-administered anticancer medications, with protections against increased patient costs and a mandated GAO study on the law's impact. H.R. 3521: Clinical Trials Modernization Act - Increase clinical trial participation among underrepresented populations by providing grants, permitting certain participant reimbursements, and offering tax exclusions, while ensuring compliance with existing legal protections. S. 705: Innovation in Pediatric Drugs Act of 2025 - amends existing laws to enhance pediatric cancer research, mandates compliance measures, allocates funding for pediatric studies, and sets guidelines for orphan drugs, with specific timelines for implementation and evaluation. H.R. 5509/S. 2903: Safe Step Act - to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. H.R. 4425/S. 2287: Palliative Care and Hospice Education and Training Act - expands federal support for workforce development, education, public awareness, and research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses. Budget/Appropriations: FY 2026 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP).

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $120,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN MEDICAL ASSOCIATION

Registrant: AMERICAN MEDICAL ASSOCIATION

3rd Quarter (July 1 - Sep 30)
Oct 20, 2025

Reported lobbying issue

Labor Issues/Antitrust/Workplace: Pharmacy Benefits Manager market competition Insurance market competition Consolidation/health care sectors Tobacco: Tobacco product standard/nicotine yield Veterans: H.R. 3951, Rural Veterans Improved Access to Benefits Act of 2025, all provisions Scope of practice Budget/Appropriations: H.R. 1, One Big Beautiful Bill Act, provisions related to Medicare Physician Payment (Section 44304), work requirements, per capita taxes, provider taxes, alternative payment models (APMs), FMAP changes, Graduate Medical Education, student loans, PBM transparency, artificial intelligence, Affordable Care Act (ACA) marketplace H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025, provisions relating to APMs, and telehealth S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026, provisions related to Medicaid, ACA and premium tax credits H.R. 5371, Continuing Appropriations and Extensions Act, 2026, provisions related to the ACA FY2026 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, provisions related to National Institutes of Health funding H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025, all provisions H.R. 929, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions S. 266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions H.R. 1585, Conrad State 30 and Physician Access Reauthorization Act, all provisions S. 709, Conrad State 30 and Physician Access Reauthorization Act, all provisions Health Resources and Services Administration (HRSA) Title VII and Title VIII programs/reauthorization Education: H.R. 2028, Resident Education Deferred Interest (REDI) Act, all provisions S. 942, Resident Education Deferred Interest (REDI) Act, all provisions H.R. 2314, Fair Access In Residency (FAIR) Act, all provisions S. 2715, Fair Access In Residency (FAIR) Act of 2025, all provisions S. 632, IHS Workforce Parity Act of 2025, all provisions H.R. 1, One Big Beautiful Bill Act, provisions relating to Graduate Medical Education, student loans H.R. 3890, Resident Physician Shortage Reduction Act of 2025, all provisions H.R. 4731, Resident Physician Shortage Reduction Act of 2025, all provisions S. 2439, Resident Physician Shortage Reduction Act of 2025, all provisions H.R. 4681, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions S. 1380, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions H.R. 3885, Community TEAMS Act of 2025, all provisions H.R. 5428, Medical Student Education Authorization Act of 2025, all provisions Health Resources and Services Administration (HRSA) Title VII and Title VIII Programs/reauthorization Health Issues: S. 891, Bipartisan Health Care Act, provisions related to expiring health care provisions H.R. 2332, States Handling Access to Reciprocity for Employment (SHARE) Act of 2025, all provisions H.R. 1521, Dental and Optometric Care (DOC) Access Act of 2025, all provisions S. 526, Pharmacy Benefit Manager Transparency Act of 2025, all provisions H.R. 4317, Pharmacy Benefit Manager (PBM) Reform Act of 2025, all provisions S. 527, Prescription Pricing for the People Act of 2025, all provisions S. 1767, Physician and Patient Safety Act, all provisions H.R. 1, One Big Beautiful Bill Act, provisions relating to artificial intelligence (AI), ACA marketplace H.R. 483, Health Care Efficiency Through Flexibility Act, all provisions S. 232, Preventing Algorithmic Collusion Act of 2025, all provisions H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025, all provisions H.R. 929, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions S. 266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions H.R. 4710, No Surprises Act Enforcement Act, all provisions S. 2420, No Surprises Act Enforcement Act, all provisions H.R. 4849, Protecting Health Care and Lowering Costs Act of 2025, all provisions H.R. 247, Health Care Affordability Act of 2025, all provisions H.R. 5145, Bipartisan Premium Tax Credit Extension Act, all provisions H.R. 2936, Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025, all provisions S. 1974, Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025, all provisions Prior authorization/AI Scope of Practice Maternal health/hypertensive disorder Vaccines Artificial Intelligence (AI) services/payment AI/use of neural data United States Preventive Services Taskforce (USPSTF)/potential elimination Drug shortages Improving maternal health outcomes Telehealth flexibilities Nutrition Cybersecurity Vehicle emission standards Health Insurance Portability and Accountability Act (HIPAA) ACA enhanced advanced premium tax credits (APTCs)/extension Immigration: H.R. 5283, Healthcare Workforce Resilience Act, all provisions S. 2759, Healthcare Workforce Resilience Act, all provisions H.R. 1585, Conrad State 30 and Physician Access Reauthorization Act, all provisions S. 709, Conrad State 30 and Physician Access Reauthorization Act, all provisions H.R. 1201, Doctors in our Borders Act, all provisions S. 2650, Directing Our Countrys Transfer of Residency Slots (DOCTORS) Act, all provisions J-1 visa/physician duration of status H-1B Visa/duration of status, and filing fees Foreign Medical Graduates/Match issues Indian/Native American Affairs: S. 632, IHS Workforce Parity Act of 2025, all provisions Indian Health Service issues Medicare/Medicaid: H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025, all provisions S. 1640, Medicare Patient Access and Practice Stabilization Act of 2025, all provisions S. 891, Bipartisan Health Care Act, provisions related to Medicare and Medicaid H.R. 786, Preserving Patient Access to Accountable Care Act, all provisions S. 1460, Preserving Patient Access to Accountable Care Act, all provisions H.R. 539, Chiropractic Medicare Coverage Modernization Act of 2025, all provisions S. 106, Chiropractic Medicare Coverage Modernization Act of 2025, all provisions H.R. 1317, Improving Care and Access to Nurses (I CAN) Act, all provisions H.R. 2191, Physician Led and Rural Access to Quality Care Act, all provisions S. 665, Fatal Overdose Reduction Act of 2025, all provisions H.R. 4977, Connected MOM Act, all provisions S. 141, Connected MOM Act, all provisions H.R. 3514, Improving Seniors Timely Access to Care Act of 2025, all provisions S. 1816, Improving Seniors Timely Access to Care Act of 2025, all provisions S. 1105, No Unreasonable Payments, Coding, Or Diagnoses for the Elderly (No UPCODE) Act, all provisions H.R. 5081, Telehealth Modernization Act, all provisions S. 2709, Telehealth Modernization Act, all provisions H.R. 1, One Big Beautiful Bill Act, provisions relating to Medicare and Medicaid physician payments, work requirements, per capita taxes, provider taxes, APMs, FMAP changes, PBM transparency H.R. 5347, Health Care Efficiency Through Flexibility Act, all provisions H.R. 2120, Radiation Oncology Case Rate (ROCR) Value Based Program Act of 2025, all provisions S. 1031, Radiation Oncology Case Rate (ROCR) Value Based Program Act of 2025, all provisions H.R. 2314, Fair Access In Residency (FAIR) Act, all provisions S. 2715, Fair Access In Residency (FAIR) Act of 2025, all provisions H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025, provisions relating to APMs H.R. 4206, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025, all provisions S. 1261, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025, all provisions H.R. 1614, To amend title XVIII of the Social Security Act to expand practitioners eligible to furnish telehealth services under the Medicare program, all provisions H.R. 3108, Rural Patient Monitoring (RPM) Access Act, all provisions S. 1535, Rural Patient Monitoring (RPM) Access Act, all provisions H.R. 3164, Ensuring Community Access to Pharmacist Services (ECAPS) Act, all provisions S. 2426, Equitable Community Access to Pharmacist Services (ECAPS) Act, all provisions H.R. 2757, Medicare Audiology Access Improvement Act of 2025, all provisions S. 1996, Medicare Audiology Access Improvement Act of 2025, all provisions H.R. 3878, RNs for Rural Health Act of 2025, all provisions H.R. 5199, Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025, al provisions H.R. 2433, Reducing Medically Unnecessary Delays in Care Act of 2025, all provisions H.R. 5467, Patient Access to Autoimmune Treatments (PAAT) Act, all provisions H.R. 4002, Patient Access to Higher Quality Health Care Act of 2025, all provisions H.R. 3022, Restoring Rights of Physicians to Own Hospitals Act, all provisions H.R. 2191, Physician Led and Rural Access to Quality Care Act, all provisions S. 1390, Physician Led and Rural Access to Quality Care Act, all provisions S. 1399, Health Tech Investment Act, all provisions H.R. 4559, Prompt and Fair Pay Act, all provisions H.R. 5454, Medicare Advantage Prompt Pay Act, all provisions S. 2879, Medicare Advantage Prompt Pay Act, all provisions H.R. 4313, Hospital Inpatient Services Modernization Act, all provisions S. 2237, Hospital Inpatient Services Modernization Act, all provisions H.R. 4752, Reducing Hereditary Cancer Act, all provisions S. 2760, Reducing Hereditary Cancer Act, all provisions S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026, provisions relating to Medicaid S.J.Res.8, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Market Integrity and Affordability," all provisions H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act, all provisions S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025, all provisions H.R. 842, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, all provisions S. 1692, Radiology Outpatient Ordering Transmission (ROOT) Act, all provisions H.R. 3890, Resident Physician Shortage Reduction Act of 2025, all provisions H.R. 4731, Resident Physician Shortage Reduction Act of 2025, all provisions S. 2439, Resident Physician Shortage Reduction Act of 2025, all provisions H.R. 4464, Preventive Health Savings Act, all provisions H.R. 2509, Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act, all provisions S. 931, Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act, all provisions Draft legislation to reform the MACRA/MIPS program Value in Health Care Act/draft GOLD CARD Act/drafts Medicare program: 21st Century Cures Act/implementation Medicare program: Medicare Economic Index (MEI) inflationary updates Medicare program: Merit-based Incentive Payment System (MIPS)/cost, quality, improvement activities, and interoperability Medicare program: MIPS Value Pathways (MVPs) reforms Medicare program: Medicare Physician Fee Schedule/efficiency adjustment, and indirect practice-expense Medicare program: Physician payment/budget neutrality Medicare program: Physician payment reform Medicare program: Kidney care models Medicare program: Coding Medicare program: G2211 Inherent Complexity Code Medicare program: Prior authorization Medicare program: Site neutral payment Medicare program: Accountable Care Organizations (ACOs)/Alternative Payment Model (APM) flexibilities Medicare program: APMs/Wasteful and Inappropriate Service Reduction (WISeR) Medicare program: APMs/Ambulatory Specialty Model (ASM) Medicare program: APM Bonus Extension Medicare program: Medicare acceptance rates, private practice issues/benchmark survey Medicare program: Relative Value Scale Update Committee (RUC) processes Medicare program: Wearables Medicare program: Local and National Coverage Determination processes Medicare program: Value-based care Medicare program: Postoperative visits Medicare program: Medicare Advantage (MA)/utilization management Medicare program: MA/prior authorization Medicare program: Promoting Interoperability (PI) Program Medicare program: Health IT/physician burdens Medicare program: Data privacy and cybersecurity Medicare program: HIPAA/electronic records Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act (MACRA)/broad reform Medicare and Medicaid programs: MACRA/physician burdens Medicare and Medicaid programs: Center for Medicare & Medicaid Innovation (CMMI) reforms Medicare and Medicaid programs: Telehealth flexibilities Medicaid: Access to care/advance premium tax credit Taxation/Internal Revenue Code: H.R. 1, One Big Beautiful Bill Act, provisions related to specified service trades or businesses, pass-through entity, and state and local tax deductions H.R. 4849, Protecting Health Care and Lowering Costs Act of 2025, all provisions H.R. 247, Health Care Affordability Act of 2025, provisions related to premium tax credits H.R. 5145, Bipartisan Premium Tax Credit Extension Act, all provisions S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026, provisions related to premium tax credits ACA enhanced premium tax credit

Government entities reported: HOUSE OF REPRESENTATIVES Medicare Payment Advisory Commission (MedPAC) SENATE Food & Drug Administration (FDA) Environmental Protection Agency (EPA) Health & Human Services, Dept of (HHS) Homeland Security, Dept of (DHS) Centers For Medicare and Medicaid Services (CMS) Government Accountability Office (GAO) Office of Technology Policy (OTP)

Reported filing-period amount: $4,620,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN TRUCKING ASSOCIATIONS

Registrant: AMERICAN TRUCKING ASSOCIATIONS

3rd Quarter (July 1 - Sep 30)
Oct 20, 2025

Reported lobbying issue

Environment/Superfund: H.R. 346 / S. 996 - Preserving Choice in Vehicle Purchase Act; H.R. 2814 / S. 711 - Transportation Freedom Act; S. 990 Freedom to Haul Act; H.R. 2218 / S. 1027 - Stop CARB Act; H.R. 2140 - Diesel Emissions Reduction Act; S. 25 - Polluters pay Climate Fund Act; H.R. 2460 - Eliminating the RFS and its Destructive Outcomes Act; Environmental issues related to Hazardous Materials, Air Quality, Vehicle Emissions, Diesel Issues (retrofits), Motor Carriers, Biodiesel/Renewable Diesel, EPA SmartWay Voluntary Program, GHG/FE Phase 3 Labor Issues/Antitrust/Workplace: H.R. 623 / S. 191 - The LICENSE Act; S. 844 - Faster Labor Contracts Act; H.R. 2945 / 1537 - Veterans Transition to Trucking Act; H.R. 3055 - TRANSPORT Jobs Act; H.R. 4049 - Employer Directed Skills Act; H.R. 5109 - The TWICE Act; H.R. 982 - Warriors to Workforce Act; H.R. 5295 - ACCESS Act; H.R. 5296 - BUILDS Act; H.R. 5297 - PARTNERS Act; H.R. 5563 - Drive Safe Act; H.R. 1232 / S. 533 - Nationwide Right-to-Work Act H.R. 1319 / S. 2228 - Modern Worker Empowerment Act; H.R. 1320 - Modern Worker Security Act; H.R. 20 / S. 852 - Protecting the Right to Organize Act; H.R. 1962 / S. 893 - Guaranteeing Overtime for Trucks Act; H.R. 4500 - HELP Act; and H.R. 4896 / S. 2613 - Warehouse Working Protection Act Implementation of H.R. 1 - One Big Beautiful Bill Act - provisions related to workforce Pell Grants. H. Res 508 / S. Res 225 - Resolution Recognizing Truck Driver Appreciation Week; and Other workforce and labor issues included Hours of Service reform, Independent Contractors, Truck Driver Shortages, Veteran Employment Training Act, the NLRB, and the Fair Labor Standards Act Small Business: H.R. 354 - Small Business Growth Act. Small business issues related to Truck Driver Training, Hazardous Materials, Border Security and Safety, Transportation Security, Homeland Security Issues, Trucking/Motor Carrier Issues, Taxes, Fuel, Independent Contractors, Hours of Service Taxation/Internal Revenue Code: H.R. 2424 - the Modern, Clean and Safe Trucks Act; H.R. 2391 - the Strengthening Supply Chains through Truck Driver Incentives Act; H.R. 1301 / S. 587 - Death Tax Repeal Act; H.R. 574, S.187 - The Align Act; H.R. 703 / S. 213 - Main Street Tax Certainty Act; H.R. 1177 / S 492 - Improve and Enhance Work Opportunity Act; H.R. 1253 / S. 536 - Fair Share Act; H.R. 3338 - MARKET Choice Act; and H.R. 3401 / S. 2790 - Retreated Truck Tire Jobs, Supply Chain Security and Sustainability Act Implementation of H.R. 1 - One Big Beautiful Bill Act - Tax and workforce provisions related to passthrough entities. Tax issues relating to Motor Carrier Tax, Highway Reauthorization, Highway Funding, Fuel Tax, Independent Contractors, Tolling, Heavy Vehicle Use Tax, Federal Highway Trust Fund, Alternative Fuel Tax Credit and the Biodiesel Tax Credit, and the Moving Expense Tax Deduction Roads/Highway: H.R.1659 - Truck Parking Safety Improvement Act; H.R. 3972 / S. 1066 - Highway Funding Flexibility Act; H.R. 352 - A Bill to Prohibit Cordon Pricing in the Central Business District Tolling Program for New York City; H.R. 351 - A Bill to Prohibit Congestion or Cordon Pricing in a Value Pricing; and H.R. 851 / S. 415 - DOT Victim and Survivor Advocate Act Other road/highway issues relating to highway funding, highway infrastructure, motor carrier taxes, public private partnerships, hours of service, truck productivity, tolling and devolution, truck-only vehicle miles traveled taxes Trucking/Shipping: H.R.2514 - the Trucker Bathroom Access Act; H.R. 2920 / S.2108 - VARIANCE Act; H.R. 4802 - Securing Infrastructure from Adversaries Act; H.R. 4661 - America DRIVES Act; S. 2290 Collision Avoidance Systems Act; and H.R. 5423 - Predatory Truck Leasing Prevention Act Other Trucking issues include Hazardous Materials, Government Traffic, Hours of Service, Public Private Partnerships, Tolling, Background Check, Highway Funding, Transportation Worker ID, Fuel Supply and Cost Issues, Economic Issues and Federal Pre-emption Budget/Appropriations: H.R. 4552 / S. 2465 - Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026 - provisions related to alternative warning devices, cargo theft reports, ELDT training prover registry, English language proficiency, human trafficking, federal preemption determination; marijuana impartment standards, predatory towing report language Safe Driver Apprenticeship Pilot Program and trucking parking language; H.R. 4249 - Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations Act, 2026, provisions related to hair testing reports, and IC Rule funding; H.R. 4213 - Homeland Security Appropriations Bill, 2026 - provisions related to cargo theft report language; and H.R. 4752 - Department of Interior and related Agencies Act, 2026 - provisions related to EPA GHG3 rules. Other Appropriations Issues related to Transportation, Transportation Security, Homeland Security, Environmental, Hours of Service, Motor Carrier Safety, Productivity, Tolling, Highway Trust Fund, Hair Testing, Independent Contractors, Younger Driver Pilot Program, Apprenticeship Programs Trade (domestic/foreign): H.R. 252 - Secure Our Ports Act; H.R. 1297 - Land Port of Entry Modernization Trust Fund Act; H.R. 1297 / S. 578 - BEST Facilitation Act; H.R. 2444 / S. 257 - Promoting Resilient Supply Chains Act; and H.R. 3630 / S. 711 - International Bridge and Port of Entry Modernization Act. Law Enforcement/Crime/Criminal Justice: H.R. 880 / S. 337 - Household Goods Shipping Consumer Protection; H.R. 863 / S. 61 - National Human Trafficking Database Act; H.R. 1569 / S. 703 - Catch Fentanyl Act; H.R. 3698 - Conors Law; H.R. 3799 - Executive Order 14286 Act of 2025; H.R. 2853 / S.1404 - Combatting Organized Retail Crime Act; S. 1442 - Combating Trafficking in Transportation Act; H.R. 4320 - DAC Safety Act; S. 2238 / H.R. 5221 - The PART Act; S. 2690 - Safer Truckers Act; and H.R. 5177 - Weigh Act. Torts: H.R. 1109 - Litigation Transparency Act; H.R. 2662 - Staged Accident Fraud Prevention Act; H.R. 2675 - Protecting Our Courts from Foreign Manipulation Act; H.R. 3512 / S. 1821 - Tackling Predatory Litigation Funding Act; H.R. 5258 - Lawsuit Abuse Reduction Act; and H.R. 5268 - FAIR Trucking Act.

Government entities reported: Environmental Protection Agency (EPA) Federal Highway Administration (FHA) HOUSE OF REPRESENTATIVES SENATE White House Office Federal Motor Carrier Safety Administration Labor, Dept of (DOL) Transportation, Dept of (DOT) Homeland Security, Dept of (DHS) Internal Revenue Service (IRS) Office of Management & Budget (OMB) U.S. International Trade Commission (ITC) U.S. Trade Representative (USTR)

Reported filing-period amount: $620,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

ASSOCIATION FOR CLINICAL ONCOLOGY

Registrant: ASSOCIATION FOR CLINICAL ONCOLOGY

3rd Quarter (July 1 - Sep 30)
Oct 17, 2025

Reported lobbying issue

Medicare/Medicaid: H.R. 3514/S. 1816: Improving Seniors' Timely Access to Care Act of 2025 - requires Medicare Advantage plans to implement electronic prior authorization, increase transparency, protect enrollees, and adhere to new response timeframes to improve timely access to care. S. 1640: Medicare Patient Access and Practice Stabilization Act of 2025 - The bill extends Medicare payment adjustment timelines to 2025 and introduces an 8.51 percent adjustment for services between June 1, 2025, and January 1, 2026, to support healthcare providers in adapting to payment changes. S. 1460: Preserving Patient Access to Accountable Care Act - extends Medicare incentive payments for alternative payment models to 2027, with a new rate of 3.53 percent, to promote continued participation and improve healthcare efficiency. H.R. 4206/S. 1261: CONNECT for Health Act - expands access to telehealth services under Medicare H. 879: Medicare Patient Access and Practice Stabilization Act - Providing automatic inflationary updates to Medicare physician payments. Eliminate budget neutrality requirements. Meaningful changes to the Merit-Based Incentive Payment System (MIPS). H.R. 786: Preserving Patient Access to Accountable Care Act. Incentivizing the transition to value-based care. H.R. 2433: Reducing Medically Unnecessary Delays in Care Act - mandates that prior authorization decisions under Medicare be made by qualified physicians, based on medical necessity and evidence-based standards, with transparency and input from practicing physicians. H.R. 1509/S. 752: Accelerating Kids Access to Care Act - To amend titles XIX and XXI of the Social Security Act to streamline the enrollment process for eligible out-of-state providers under Medicaid and CHIP. H.R. 2484: Seniors' Access to Critical Medications Act of 2025 - establishes an exception to the physician self-referral prohibition for certain outpatient drugs under Medicare, mandates a study on drug dispensing practices, and reduces the Medicare improvement fund by $18 million. H.R. 2120/S. 1031: ROCR Value Based Program Act - establishes a new payment program for radiation oncology services, focusing on stable payments, quality care, and patient access, while exempting it from budget neutrality adjustments. H.R. 4559: Prompt and Fair Pay Act - to establish payment parity between Medicare Advantage and fee-for-service Medicare, and to establish prompt payment requirements under Medicare Advantage. H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act - provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation. H.R. 5081/S. 2709: Telehealth Modernization Act - to extend certain telehealth flexibilities under the Medicare program. H.R. 4752/S. 2760: Reducing Hereditary Cancer Act - to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation Preserving the Medicaid Program for cancer patients. Health Issues: S. 864: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 1262/S. 932: Give Kids a Chance Act of 2025 - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. HR 929/S.266: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act - To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes. H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4191: To improve coordination of Federal efforts to identify and mitigate health and national security risks through maintaining a list of essential medicines, conducting a risk assessment of essential medicine supply chains, and creating a monitoring system to map essential medicine supply chains using data analytics. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral anticancer drugs that is at least as favorable as for provider-administered anticancer medications, with protections against increased patient costs and a mandated GAO study on the law's impact. H.R. 3521: Clinical Trials Modernization Act - Increase clinical trial participation among underrepresented populations by providing grants, permitting certain participant reimbursements, and offering tax exclusions, while ensuring compliance with existing legal protections. S. 705: Innovation in Pediatric Drugs Act of 2025 - amends existing laws to enhance pediatric cancer research, mandates compliance measures, allocates funding for pediatric studies, and sets guidelines for orphan drugs, with specific timelines for implementation and evaluation. H.R. 5509/S. 2903: Safe Step Act - to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. H.R. 4425/S. 2287: Palliative Care and Hospice Education and Training Act - expands federal support for workforce development, education, public awareness, and research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses. Cures 2.1 Tobacco: Support banning the sale of menthol cigarettes and flavored cigars Support regulating the sale of flavored tobacco and electronic nicotine devices Budget/Appropriations: FY 2025 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP) and palliative care research. FY 2026 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP). H.R. 1: One Big Beautiful Bill Act - Provisions related to Medicare physician payment, PBM reform, Medicaid

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $110,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN

Registrant: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN

2nd Quarter (Apr 1 - June 30)
Jul 21, 2026

Reported lobbying issue

Budget/Appropriations: H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; a bill making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2027, and for other purposes H.R.9495 - Department of Defense Appropriations Act, 2027; a bill making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; a bill making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. FY27 appropriations related to funding for biomedical research, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding, and related cancer services Insurance: H.R.3037/S.1500 - Access to Breast Cancer Diagnosis Act; a bill to eliminate cost sharing for medically necessary diagnostic and supplemental breast imaging for patients with private insurance Medicare/Medicaid: H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act; a bill to amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with metastatic breast cancer, and for other purposes H.R.6280/S.3607- Access to Genetic Counselor Services Act of 2026; a bill to amend title XVIII of the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under part B of the Medicare program, and for other purposes. H.R.4752/S.27060 - Reducing Hereditary Cancer Act; a bill to amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer. Comments in response to Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges (CMS-0062-P) Activities related to the implementation of H.R. 1 the One Big Beautiful Bill Act Health Issues: H.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.4541/S.2339 - The EARLY Act Reauthorization of 2025; a bill to reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research. H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026; a bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivors background, or forthcoming survivorship needs, and for other purposes. H.R.3521/S.4440 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes. H.Res.1196 - Recognizing April as Cancer Prevention and Early Detection Month; a House resolution to recognize April as Cancer Prevention and Early Detection month Efforts to introduce legislation related to the establishment of an interagency task force on breast cancer risk assessment tools Efforts related to the Office of Management and Budget Proposed Rule to revise the Guidance for Federal Financial Assistance Comments related the CMS Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model and Medicares six protected classes Postal: H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS) Health & Human Services, Dept of (HHS) Office of Management & Budget (OMB)

Reported filing-period amount: $130,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗
Discussion notificationsSign in to subscribe
?
No comments yet. Start the conversation.